Skip to main content

ORIGINAL RESEARCH article

Front. Public Health
Sec. Public Health Education and Promotion
Volume 12 - 2024 | doi: 10.3389/fpubh.2024.1406861
This article is part of the Research Topic Building Public Confidence in Innovative mRNA Vaccines View all 9 articles

A Global Survey to Understand General Vaccine Trust, COVID-19 and Influenza Vaccine Confidence

Provisionally accepted
Chelsea D'Silva Chelsea D'Silva 1*Madison M. Fullerton Madison M. Fullerton 1,2Jia Hu Jia Hu 1,2Kenneth Rabin Kenneth Rabin 3Scott Ratzan Scott Ratzan 3
  • 1 19 to Zero Inc., Calgary, Canada
  • 2 University of Calgary, Calgary, Alberta, Canada
  • 3 City College of New York (CUNY), New York City, New York, United States

The final, formatted version of the article will be published soon.

    The COVID-19 pandemic has greatly impacted the way that the world views vaccines. While safe and effective, COVID-19 vaccines were, and continue to be met with hesitancy and misinformation. We aimed to understand public perceptions and trust in COVID-19 vaccinations and how the pandemic has impacted perceptions of non-COVID-19 vaccines.Methods: Survey data were collected between August 7, 2023 -August 16, 2023, from 7,000 respondents aged 18 years and older from the United States (n=1,000); Nigeria (n=1,000); United Kingdom (n=1,000); France (n=1,000); Canada (n=1,000); Brazil (n=1,000); and India (n=1,000).Results: Trust in COVID-19 vaccines was highest in Brazil (84.6%) and India (80.4%) and lowest in the United States (63.5%) and France (55.0%). 47.5% of respondents agreed that they trust traditional protein-based vaccines more than mRNA vaccines, 13.5% disagree and 39.0% are neutral about their trust in protein-based versus mRNA vaccines. Overall, 53.9% of respondents reported that the COVID-19 pandemic impacted their perceptions of vaccines with half of these respondents (51.7%) reporting that the pandemic made them think that other vaccines are more important as they understand how critical vaccines can be at preventing serious illnesses.Discussion: These data can be used by health system decision makers, public health and researchers to understand how vaccine trust impacts perceptions of COVID-19 and influenza vaccines globally and develop tailored interventions that address local concerns.

    Keywords: Vaccine trust, COVID-19, vaccine confidence, Immunization, mRNA

    Received: 25 Mar 2024; Accepted: 18 Oct 2024.

    Copyright: © 2024 D'Silva, Fullerton, Hu, Rabin and Ratzan. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

    * Correspondence: Chelsea D'Silva, 19 to Zero Inc., Calgary, Canada

    Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.